Patents by Inventor John Pierce

John Pierce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070090646
    Abstract: A coupling for joining pipe elements in end to end relation is disclosed. The coupling includes interconnectable coupling segments having connection members at opposite ends. The connection members are tightenable for drawing the segments toward one another and into engagement with the pipe elements. Each segment has a concavity positioned between inwardly projecting arcuate surfaces that engage grooves in the pipe elements. The concavities house a sealing member that extends circumferentially around the pipe elements. Angularly oriented surfaces are positioned adjacent to the connection members. The surfaces on facing segments engage one another and cause the segments to rotate in opposite directions about an axis perpendicular to the pipe elements. The concavities are angularly oriented with respect to the axis so that when the segments rotate, the cavities receive the sealing member without distorting it. A method of joining pipe elements end to end is also disclosed.
    Type: Application
    Filed: October 26, 2006
    Publication date: April 26, 2007
    Applicant: Victaulic Company
    Inventors: Douglas Dole, Michael Porter, Scott Madara, William Nagle, John Pierce, William McPoyle
  • Publication number: 20060285759
    Abstract: An aspect of the present invention includes a method of encoding coefficients of a subband decomposition, to prepare the coefficients for compression. Another aspect of the present invention includes an inverse method of decoding coefficients of a subband decomposition, after they have been decompressed. Particular features and other aspects of the present invention are indicated in the specification, including the drawings and claims.
    Type: Application
    Filed: May 25, 2006
    Publication date: December 21, 2006
    Applicant: KT-Tech, Inc.
    Inventors: Robert Buccigrossi, Bao Lerner, John Pierce
  • Publication number: 20060251742
    Abstract: The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.
    Type: Application
    Filed: February 16, 2006
    Publication date: November 9, 2006
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Publication number: 20060251715
    Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.
    Type: Application
    Filed: May 2, 2006
    Publication date: November 9, 2006
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Patent number: 7105185
    Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. A material having a preferred kavalactone distribution profile is also disclosed. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: September 12, 2006
    Assignee: HerbalScience, LLC
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Patent number: 7037524
    Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: May 2, 2006
    Assignee: HerbalScience, LLC
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Patent number: 7029707
    Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones is also disclosed.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: April 18, 2006
    Assignee: HerbalScience, LLC
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Patent number: 7001620
    Abstract: The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: February 21, 2006
    Assignee: Herbal Science, LLC
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Publication number: 20050118293
    Abstract: The present invention comprises methods for making compositions derived from Ilex species, particularly Ilex paraguariensis, having lowered caffeine and tannin concentrations, compositions made by such methods, oral delivery formulations, and methods of use of such compositions. In particular, the present invention comprises methods for making maté compositions that have a predetermined characeteristic, such as a lowered amount of caffeine, elevated amounts of caffeoyls, and/or lowered amounts of tannin compounds compared to the native maté plant materials. Further, the invention comprises methods of additional processing steps to produce compositions having a predetermined alkaloid ratio or profiles to meet particular considerations for final products. The compositions of the present invention may be processed for specific uses such as tablets or other oral delivery vehicles. These compositions may be used in methods for treatment of physiological and medical conditions.
    Type: Application
    Filed: October 25, 2004
    Publication date: June 2, 2005
    Inventors: Robert Gow, George Sypert, John Pierce, Dan Li, Xun Yan, Rodger Marentis
  • Publication number: 20050101022
    Abstract: An apparatus and process are described in which a plurality of preloaded catalyst samples tubes can be serially and automatically moved from a support to a reaction zone where each catalyst sample can be heated and a preheated reagent feed contacted with the sample and the effluent fed to a product collection and analysis system.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 12, 2005
    Inventors: Stephen Vaughn, John Pierce, Douglas King, Christopher Lington
  • Publication number: 20050089584
    Abstract: The present invention comprises methods and compositions comprising Areca extract compositions and compositions comprising extracts of Ilex paraguariensis or theobromine. Methods of the invention comprise methods of making pharmaceutical or nutriceutical products comprising Areca catechu extract compositions and mate' extract compositions or theobromine, and methods of use of the extracted products and pharmaceutical and nutriceutical products. The present invention also comprises methods for treating conditions related to mental and physical fatigue and obesity, as well as, enhancement of mental focus, cognition, and a sense of well being, comprising administering the compositions of the present invention.
    Type: Application
    Filed: September 20, 2004
    Publication date: April 28, 2005
    Inventors: Robert Gow, John Pierce, George Sypert
  • Publication number: 20050089591
    Abstract: The present invention comprises methods for making compositions derived from Ilex species, particularly Ilex paraguariensis, having lowered caffeine and tannin concentrations, compositions made by such methods, oral delivery formulations, and methods of use of such compositions. In particular, the present invention comprises methods for making maté compositions that have a predetermined characeteristic, such as a lowered amount of caffeine, elevated amounts of caffeoyls, and/or lowered amounts of tannin compounds compared to the native maté plant materials. Further, the invention comprises methods of additional processing steps tp produce compositions having a predetermined alkaloid ratio or profiles to meet particular considerations for final products. The compositions of the present invention may be processed for specific uses such as tablets or other oral delivery vehicles. These compositions may be used in methods for treatment of physiological and medical conditions.
    Type: Application
    Filed: October 21, 2004
    Publication date: April 28, 2005
    Inventors: Robert Gow, George Sypert, John Pierce, Dan Li, Xun Yan, Rodger Marentis
  • Publication number: 20050078874
    Abstract: An aspect of the present invention includes a method of encoding coefficients of a subband decomposition, to prepare the coefficients for compression. Another aspect of the present invention includes an inverse method of decoding coefficients of a subband decomposition, after they have been decompressed. Particular features and other aspects of the present invention are indicated in the specification, including the drawings and claims.
    Type: Application
    Filed: August 23, 2004
    Publication date: April 14, 2005
    Applicant: KT-Tech, Inc.
    Inventors: Robert Buccigrossi, Bao Lerner, John Pierce
  • Publication number: 20050069596
    Abstract: The present invention comprises compositions comprising combinations of kava extract compositions in combination with one or more anxiolytics and methods for treating conditions related to the various anxiety disorders comprising administering the compositions of the present invention. The invention further provides methods for enhancing the therapeutic activity of an anxiolytic comprising administering the anxiolyitc in combination with extract of Piper methysticin.
    Type: Application
    Filed: September 20, 2004
    Publication date: March 31, 2005
    Inventors: Robert Gow, John Pierce, George Sypert
  • Publication number: 20050053678
    Abstract: The present invention relates to methods and compositions comprising Areca catechu extracts and Piper betel extracts. Compositions comprise Areca catechu extracts that comprise alkaloid compounds in ratios that are different from the ratios found in native Areca plant material. Methods of the present invention comprise extractions of Areca catechu and Piper betel, making the compositions comprising Areca catechu and Piper betel and methods of providing compositions that mimic the effects in humans of chewing betel quid and have reduced carcinogenicity.
    Type: Application
    Filed: September 20, 2004
    Publication date: March 10, 2005
    Inventors: Robert Gow, John Pierce, George Sypert
  • Publication number: 20050037025
    Abstract: The present invention comprises compositions comprising combinations of compositions of extracts of kava mate' extract compositions or theobromine. The invention further comprises methods for treating conditions related to mental and physical fatigue, anxiety, muscle tension, nervous depression, headache, obesity, and mild pain as well a enhancement of cognition and mental focus comprising administering effective amounts of the compositions of the present invention.
    Type: Application
    Filed: September 20, 2004
    Publication date: February 17, 2005
    Inventors: Robert Gow, John Pierce, George Sypert
  • Publication number: 20040202738
    Abstract: This invention comprises methods and compositions of areca catechu. Methods of the present invention comprise extracting plant material of areca catechu so that compositions having characteristics different from those of native plant materials are obtained. Compositions comprising food aids and other dietary supplements are also taught.
    Type: Application
    Filed: April 5, 2004
    Publication date: October 14, 2004
    Inventors: Robert T. Gow, Brian Pierce, John Pierce, William Birdsall
  • Publication number: 20040202730
    Abstract: This invention is related to an improved composition for treating heart conditions. More specifically, the present invention is related to an improved composition for treating heart conditions containing borneol, rosmarinic acid and a ginsenoside selected from the group consisting of ginsenoside Rg1 and ginsenoside Rb1.
    Type: Application
    Filed: April 8, 2003
    Publication date: October 14, 2004
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
  • Publication number: 20040202731
    Abstract: This invention is related to methods and compositions comprising rosmarinic acid. More specifically, the present invention comprises compositions comprising borneol, rosmarinic acid and at least one ginsenoside.
    Type: Application
    Filed: April 5, 2004
    Publication date: October 14, 2004
    Inventors: Robert T. Gow, Brian Pierce, John Pierce, William Birdsall
  • Publication number: 20040081664
    Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.
    Type: Application
    Filed: October 18, 2002
    Publication date: April 29, 2004
    Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall